IRS1 and metabolic dysfunction-associated steatotic liver disease: Consistent with this notion, Irs1 expression was maintained or rather increased, and Irs2 expression was reduced in the liver biopsy specimens obtained from patients with nonalcoholic fatty liver disease (NAFLD) (Fig. 1a).